Video-Monitoring Could Be the Key to Making At-Home Addiction Treatment Safer and More Effective
Sebastian Seiguer, CEO of Scene Health, formerly emocha Health, and Dr. Kevin Hallgren of the University of Washington School of Medicine discuss the implications of video observation of methadone dosing for patient safety, policy and the behavioral health backlog. Dr. Hallgren is the lead author of a study published in the Journal of Substance Abuse Treatment (Oct 4, 2022), conducted in conjunction with Scene Health, that evaluated the feasibility, acceptability, and engagement with smartphone-based video observation of methadone take-home dosing.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on COVID. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in COVID and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about COVID?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic – Journal of Substance Abuse Treatment
Sebastian is the CEO and co-founder of Scene (previously emocha), a medication engagement company that provides personalized, breakthrough medication support by combining video technology, clinical coaching, and validated interventions to radically improve medication adherence rates. In 2014, Sebastian spun Scene out of Johns Hopkins with Dr. Bob Bollinger and other medication adherence experts to help communities served by public health departments, health plans including Medicaid and Medicare, and health systems. Scene is now the standard of care for infectious disease adherence monitoring and is scaling quickly. Sebastian started his career as an attorney with Allen & Overy in London before launching his first company in Munich, Germany, in 2000. He earned his law degree from Columbia Law School and his MBA in Health Care from Johns Hopkins University.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
